Item 8.01. Other Events.
On January 27, 2020, Merit Medical Systems, Inc. (the "Company") issued a press
release announcing that the Company had received a notice on January 24, 2020
from Starboard Value LP ("Starboard") of Starboard's intention to nominate
individuals to the Company's Board of Directors at the Company's 2020 Annual
Meeting of Shareholders. A copy of the Company's press release is filed as
Exhibit 99.1 hereto and is incorporated herein by reference.
Important Additional Information and Where to Find It
The Company plans to file a proxy statement (the "2020 Proxy Statement") with
the SEC in connection with the solicitation of proxies for the Annual Meeting,
together with a BLUE proxy card. SHAREHOLDERS ARE URGED TO READ THE 2020 PROXY
STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER
RELEVANT DOCUMENTS THAT THE COMPANY FILES WITH THE SEC CAREFULLY IN THEIR
ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT
INFORMATION.
Shareholders will be able to obtain, free of charge, copies of the 2020 Proxy
Statement, any amendments or supplements thereto and any other documents
(including the BLUE proxy card) when filed by the Company with the SEC in
connection with the Annual Meeting at the SEC's website (http://www.sec.gov), at
the Company's website (http://www.merit.com/investors) or by contacting
Innisfree M&A Incorporated by phone at (888) 750-5834, by email at
info@innisfreema.com or by mail at 501 Madison Avenue, 20th Floor, New York, NY
10022.
Item 9.01.Financial Statements and Exhibits.
(d) Exhibit
EXHIBIT NUMBER DESCRIPTION
99.1 Press Release, dated January 27, 2020, entitled "Merit Medical
Issues Statement Regarding Director Nominations from Starboard."
104 Cover Page Interactive Data File - the cover page XBRL tags are
embedded within the Inline XBRL document
2
© Edgar Online, source Glimpses